Keywords: betaferon, beats, rivals, japanese, market, schering, ag
Betaferon beats rivals to Japanese market
Article | 28 November 2000
Schering AG of Germany has launched its multiple sclerosis drugBetaferon (interferon beta-1b) in Japan, where there are approximately 7,000 sufferers ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
